JPWO2020111167A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020111167A5
JPWO2020111167A5 JP2020557810A JP2020557810A JPWO2020111167A5 JP WO2020111167 A5 JPWO2020111167 A5 JP WO2020111167A5 JP 2020557810 A JP2020557810 A JP 2020557810A JP 2020557810 A JP2020557810 A JP 2020557810A JP WO2020111167 A5 JPWO2020111167 A5 JP WO2020111167A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
seq
peptide
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020557810A
Other languages
English (en)
Japanese (ja)
Other versions
JP7525855B2 (ja
JPWO2020111167A1 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/046505 external-priority patent/WO2020111167A1/ja
Publication of JPWO2020111167A1 publication Critical patent/JPWO2020111167A1/ja
Publication of JPWO2020111167A5 publication Critical patent/JPWO2020111167A5/ja
Priority to JP2024005446A priority Critical patent/JP7726464B2/ja
Application granted granted Critical
Publication of JP7525855B2 publication Critical patent/JP7525855B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020557810A 2018-11-30 2019-11-28 Big3-phb2相互作用阻害phb2由来ペプチドを含む乳がん治療薬 Active JP7525855B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024005446A JP7726464B2 (ja) 2018-11-30 2024-01-17 Big3-phb2相互作用阻害phb2由来ペプチドを含む乳がん治療薬

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018225660 2018-11-30
JP2018225660 2018-11-30
PCT/JP2019/046505 WO2020111167A1 (ja) 2018-11-30 2019-11-28 Big3-phb2相互作用阻害phb2由来ペプチドを含む乳がん治療薬

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024005446A Division JP7726464B2 (ja) 2018-11-30 2024-01-17 Big3-phb2相互作用阻害phb2由来ペプチドを含む乳がん治療薬

Publications (3)

Publication Number Publication Date
JPWO2020111167A1 JPWO2020111167A1 (ja) 2021-10-28
JPWO2020111167A5 true JPWO2020111167A5 (cg-RX-API-DMAC7.html) 2022-11-21
JP7525855B2 JP7525855B2 (ja) 2024-07-31

Family

ID=70853835

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020557810A Active JP7525855B2 (ja) 2018-11-30 2019-11-28 Big3-phb2相互作用阻害phb2由来ペプチドを含む乳がん治療薬
JP2024005446A Active JP7726464B2 (ja) 2018-11-30 2024-01-17 Big3-phb2相互作用阻害phb2由来ペプチドを含む乳がん治療薬

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024005446A Active JP7726464B2 (ja) 2018-11-30 2024-01-17 Big3-phb2相互作用阻害phb2由来ペプチドを含む乳がん治療薬

Country Status (4)

Country Link
US (3) US12595289B2 (cg-RX-API-DMAC7.html)
EP (1) EP3889264A4 (cg-RX-API-DMAC7.html)
JP (2) JP7525855B2 (cg-RX-API-DMAC7.html)
WO (1) WO2020111167A1 (cg-RX-API-DMAC7.html)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8516611D0 (en) 1985-07-01 1985-08-07 Du Pont Canada Fire-retardant sheet material
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
GB9201180D0 (en) 1992-01-21 1992-03-11 Glaxo Group Ltd Chemical compounds
US5804566A (en) 1993-08-26 1998-09-08 The Regents Of The University Of California Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
US5679647A (en) 1993-08-26 1997-10-21 The Regents Of The University Of California Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
US5739118A (en) 1994-04-01 1998-04-14 Apollon, Inc. Compositions and methods for delivery of genetic material
US5736524A (en) 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
AU7335396A (en) 1995-11-01 1997-05-22 Dnavec Research Inc. Membrane-fusible liposome with the use of recombinant sendai virus
JP2000516090A (ja) 1996-07-26 2000-12-05 スローン―ケッタリング インスティチュート フォー キャンサー リサーチ 遺伝子的免疫化のための方法と試薬
AU749544B2 (en) 1998-06-25 2002-06-27 Dainippon Sumitomo Pharma Co., Ltd. Tumor antigen peptides originating in cyclophilin B
US7998695B2 (en) 2005-02-10 2011-08-16 Oncotherapy Science, Inc. Method of diagnosing bladder cancer
JP5339291B2 (ja) 2006-08-10 2013-11-13 オンコセラピー・サイエンス株式会社 乳癌に関連する遺伝子およびポリペプチド
DK2738255T3 (en) 2011-07-29 2017-03-06 Univ Tokushima ERAP1-Derived Peptide and its Use
JP6923135B2 (ja) 2016-01-19 2021-08-18 国立大学法人徳島大学 がん治療用ペプチド及びそれを含む医薬組成物
CN111148752B (zh) 2017-07-19 2024-01-16 国立大学法人德岛大学 肽衍生物和包含其的药物组合物

Similar Documents

Publication Publication Date Title
CN110511280B (zh) 一种透皮重组纤连蛋白及其应用
AU727662B2 (en) Peptides having antiproliferative properties
JP2023514611A5 (cg-RX-API-DMAC7.html)
HK1208040A1 (en) Cell penetrating peptides to target eif4e
CN114053427B (zh) 一种多肽靶向药物及其制备方法和应用
JP2015522264A (ja) 細胞透過性ペプチドおよび細胞透過性ペプチドを同定する方法
Chang et al. Expression in Escherichia coli of open reading frame gene segments of HTLV-III
JP2980334B2 (ja) ラットの顎下腺から導出したペプチド及びポリペプチド、対応するポリクローナル及びモノクローナル抗体、対応するハイブリドーマ並びに診断、検出及び治療目的でのこれらの生成物の使用
FI4034555T3 (fi) Dap10/dap12-fuusiopolypeptidit
CN100577686C (zh) 寡聚肽及其治疗hiv感染的用途
RU98112759A (ru) Человеческий семафорин l (h-sema-l) и соответствующие семафорины в других видах
US20190100557A1 (en) Protransduzin b, a gene transfer enhancer
Wojciechowska et al. Synthesis and hybridization studies of a new CPP-PNA conjugate as a potential therapeutic agent in atherosclerosis treatment
Cross et al. Influence of α-helicity, amphipathicity and D-amino acid incorporation on the peptide-induced mast cell activation
CN118772232B (zh) 蛙皮素类多肽化合物及其用途
US20220340629A1 (en) Myosin Derived Peptides and Related Compounds with Anticoagulant Activities
Imhof et al. Synthesis of linear and cyclic phosphopeptides as ligands for the N‐terminal SH2‐domain of protein tyrosine phosphatase SHP‐1
JPH06228002A (ja) Pacapを含有するセクレトグラニンιι産生促進剤
CN112390874B (zh) 一种合成多肽及其合成方法和应用
JP7726464B2 (ja) Big3-phb2相互作用阻害phb2由来ペプチドを含む乳がん治療薬
JP2793216B2 (ja) 粘膜による吸収を高める、ソルビン及び誘導ペプチド
AU2017358552B2 (en) Protransducine-C: gene transfer activator
WO2025193770A1 (en) Macrocyclic peptides
CN112209991A (zh) APC/Asef相互作用的三肽抑制剂及其应用
CN120818007A (zh) Psd-95 pdz2拟肽类抑制剂及其应用